Role of fibroblast growth factor 19 in maintaining nutrient homeostasis and disease

Biomedical and Environmental Sciences

Volumn 27, Issue 5, 2014, Pages 319-324

  Zhang, Jing ^a,b   Li, Hua Ting ^a   Fang, Qi Chen ^a   Jia, Wei Ping ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; FGF19 PROTEIN, HUMAN; FIBROBLAST GROWTH FACTOR;

ANIMAL; AUTOCRINE EFFECT; CARBOHYDRATE METABOLISM; EXOCRINE GLAND; HOMEOSTASIS; HUMAN; LIPID METABOLISM; METABOLIC DISORDER; METABOLISM; PHYSIOLOGY; REVIEW;

ANIMALS; AUTOCRINE COMMUNICATION; BILE ACIDS AND SALTS; CARBOHYDRATE METABOLISM; EXOCRINE GLANDS; FIBROBLAST GROWTH FACTORS; HOMEOSTASIS; HUMANS; LIPID METABOLISM; METABOLIC DISEASES;

EID: 84901445188     PISSN: 08953988     EISSN: None     Source Type: Journal    
DOI: 10.3967/bes2014.056     Document Type: Review

References (62)

1. N Itoh Hormone-like (endocrine) Fgfs: their evolutionary history and roles in development, metabolism, and disease Cell Tissue Res 342 2010 1 11
2. M Presta, P Dell'Era, S Mitola et al. Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis Cytokine Growth Factor Rev 16 2005 159 178
3. N Itoh, DM Ornitz Functional evolutionary history of the mouse Fgf gene family Dev Dyn 237 2008 18 27
4. C Cicione, C Degirolamo, A Moschetta Emerging role of fibroblast growth factors 15/19 and 21 as metabolic integrators in the liver Hepatology 56 2012 2404 2411
5. N Itoh, DM Ornitz Evolution of the Fgf and Fgfr gene families Trends Genet 20 2004 563 569
6. T Nishimura, Y Utsunomiya, M Hoshikawa et al. Structure and expression of a novel human FGF, FGF-19, expressed in the fetal brain Biochim Biophys Acta 1444 1999 148 151
7. JR McWhirter, M Goulding, JA Weiner et al. A novel fibroblast growth factor gene expressed in the developing nervous system is a downstream target of the chimeric homeodomain oncoprotein E2A-Pbx1 Development 124 1997 3221 3232
8. T Inagaki, M Choi, A Moschetta et al. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis Cell Metab 2 2005 217 225
9. T Lundasen, C Galman, B Angelin et al. Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man J Intern Med 260 2006 530 536
10. MJ Potthoff, J Boney-Montoya, M Choi et al. FGF15/19 regulates hepatic glucose metabolism by inhibiting the CREB-PGC-1a pathway Cell Metab 13 2011 729 738
11. MH Xie, I Holcomb, B Deuel et al. FGF-19, a novel fibroblast growth factor with unique specificity for FGFR4 Cytokine 11 1999 729 735
12. DM Ornitz, N Itoh Fibroblast growth factors Genome Biol 2 2001 REVIEWS3005
13. A Beenken, M Mohammadi The FGF family: biology, pathophysiology and therapy Nat Rev Drug Discov 8 2009 235 253
14. M Asada, M Shinomiya, M Suzuki et al. Glycosaminoglycan affinity of the complete fibroblast growth factor family Biochim Biophys Acta 1790 2009 40 48
15. A Beenken, M Mohammadi The structural biology of the FGF19 subfamily Adv Exp Med Biol 728 2012 1 24
16. Y Ogawa, H Kurosu, M Yamamoto et al. BetaKlotho is required for metabolic activity of fibroblast growth factor 21 Proc Natl Acad Sci USA 104 2007 7432 7437
17. BC Lin, M Wang, C Blackmore et al. Liver-specific activities of FGF19 require Klotho beta J Biol Chem 282 2007 27277 27284
18. X Wu, H Ge, J Gupte et al. Co-receptor requirements for fibroblast growth factor-19 signaling J Biol Chem 282 2007 29069 29072
19. X Wu, H Ge, B Lemon et al. FGF19-induced hepatocyte proliferation is mediated through FGFR4 activation J Biol Chem 285 2010 5165 5170
20. X Wu, H Ge, B Lemon et al. Selective activation of FGFR4 by an FGF19 variant does not improve glucose metabolism in ob/ob mice Proc Natl Acad Sci USA 106 2009 14379 14384
21. DW Russell The enzymes, regulation, and genetics of bile acid synthesis Annu Rev Biochem 72 2003 137 174
22. NY Kalaany, DJ Mangelsdorf LXRS and FXR: the yin and yang of cholesterol and fat metabolism Annu Rev physiol 68 2006 159 191
23. DW Russell, KD Setchell Bile acid biosynthesis Biochemistry 31 1992 4737 4749
24. JY Chiang Bile acidmetabolism and signaling Compr Physiol 3 2013 1191 1212
25. J Vaquero, MJ Monte, M Dominguez et al. Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition Biochem Pharmacol 86 2013 926 939
26. S Seok, D Kanamaluru, Z Xiao et al. Bile acid signal-induced phosphorylation of small heterodimer partner by protein kinase C is critical for epigenomic regulation of liver metabolic genes J Biol Chem 288 2013 23252 23263
27. L Vergnes, JM Lee, RG Chin et al. Diet1 functions in the FGF15/19 enterohepatic signaling axis to modulate bile acid and lipid levels Cell Metab 17 2013 916 928
28. JA Holt, G Luo, AN Billin et al. Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis Genes Dev 17 2003 1581 1591
29. C Yu, F Wang, M Kan et al. Elevated cholesterol metabolism and bile acid synthesis in mice lacking membrane tyrosine kinase receptor FGFR4 J Biol Chem 275 2000 15482 15489
30. S Ito, T Fujimori, A Furuya et al. Impaired negative feedback suppression of bile acid synthesis in mice lacking betaKlotho J Clin Invest 115 2005 2202 2208
31. K Tomiyama, R Maeda, I Urakawa et al. Relevant use of Klotho in FGF19 subfamily signaling system in vivo Proc Natl Acad Sci USA 107 2010 1666 1671
32. M Choi, A Moschetta, AL Bookout et al. Identification of a hormonal basis for gallbladder filling Nat Med 12 2006 1253 1255
33. MJ Potthoff, SA Kliewer, DJ Mangelsdorf Endocrine fibroblast growth factors 15/19 and 21: from feast to famine Genes Dev 26 2012 312 324
34. E Tomlinson, L Fu, L John et al. Transgenic Mice Expressing Human Fibroblast Growth Factor-19 Display Increased Metabolic Rate and Decreased Adiposity Endocrinology 143 2002 1741 1747
35. KK Ryan, R Kohli, R Gutierrez-Aguilar et al. Fibroblast growth factor-19 action in the brain reduces food intake and body weight and improves glucose tolerance in male rats Endocrinology 154 2013 9 15
36. S Kir, SA Beddow, VT Samuel et al. FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis Science 331 2011 1621 1624
37. L Fu, LM John, SH Adams et al. Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes Endocrinology 145 2004 2594 2603
38. M Miyazaki, H Sampath, X Liu et al. Stearoyl-CoA desaturase-1 deficiency attenuates obesity and insulin resistance in leptin-resistant obese mice Biochem Biophys Res Commun 380 2009 818 822
39. L Abu-Elheiga, H Wu, Z Gu et al. Acetyl-CoA carboxylase 2-/- mutant mice are protected against fatty liver under high-fat, high-carbohydrate dietary and de novo lipogenic conditions J Biol Chem 287 2012 12578 12588
40. AF Hofmann Bile acids: trying to understand their chemistry and biology with the hope of helping patients Hepatology 49 2009 1403 1418
41. SS Pattni, JRF Walters Recent advances in the understanding of bile acid malabsorption Br Med Bull 92 2009 79 93
42. H Fromm, M Malavolti Bile acid-induced diarrhoea Clin Gastroenterol 15 1986 567 582
43. AF Hofmann The syndrome of ileal disease and the broken enterohepatic circulation: cholerhetic enteropathy Gastroenterology 52 1967 752 757
44. SS Pattni, WG Brydon, T Dew et al. Fibroblast growth factor 19 and 7a-Hydroxy-4-Cholesten-3-one in the diagnosis of patients with possible bile acid diarrhea Clin Transl Gastroenterol 3 2012 e18
45. AF Hofmann, DJ Mangelsdorf, SA Kliewer Chronic diarrhea due to excessive bile acid synthesis and not defective ileal transport: a new syndrome of defective fibroblast growth factor 19 release Clin Gastroenterol Hepatol 7 2009 1151 1154
46. JR Walters, AM Tasleem, OS Omer et al. A new mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis Clin Gastroenterol Hepatol 7 2009 1189 1194
47. SS Pattni, WG Brydon, T Dew et al. Fibroblast growth factor 19 in patients with bile acid diarrhoea: a prospective comparison of FGF19 serum assay and SeHCAT retention Aliment Pharmacol Ther 38 2013 967 976
48. D Stejskal, M Karpisek, Z Hanulova et al. Fibroblast growth factor-19: development, analytical characterization and clinical evaluation of a new ELISA test Scand J Clin Lab Invest 68 2008 501 507
49. B Barutcuoglu, G Basol, Y Cakir et al. Fibroblast Growth Factor-19 Levels in Type 2 Diabetic Patients with Metabolic Syndrome Ann Clin Lab Sci 41 2011 390 396
50. Q Fang, H Li, Q Song et al. Serum fibroblast growth factor 19 levels are decreased in chinese subjects with impaired fasting glucose and inversely associated with fasting plasma glucose levels Diabetes Care 36 2013 2810 2814
51. M Mráz, Z Lacinová, P Kaválková et al. Serum concentrations of fibroblast growth factor 19 in patients with obesity and type 2 diabetes mellitus: the influence of acute hyperinsulinemia, very-low calorie diet and PPAR-alpha agonist treatment Physiol Res 60 2011 627 636
52. D Wang, W Zhu, J Li et al. Serum Concentrations of Fibroblast Growth Factors 19 and 21 in Women with Gestational Diabetes Mellitus: Association with Insulin Resistance, Adiponectin, and Polycystic Ovary Syndrome History PLoS One 8 2013 e81190
53. M Wojcik, D Janus, K Dolezal-Oltarzewska et al. A decrease in fasting FGF19 levels is associated with the development of non-alcoholic fatty liver disease in obese adolescents J Pediatr Endocrinol Metab 25 2012 1089 1093
54. F Eren, R Kurt, F Ermis et al. Preliminary evidence of a reduced serum level of fibroblast growth factor 19 in patients with biopsy-proven nonalcoholic fatty liver disease Clin Biochem 45 2012 655 658
55. A Alisi, S Ceccarelli, N Panera et al. Association between Serum Atypical Fibroblast Growth Factors 21 and 19 and Pediatric Nonalcoholic Fatty Liver Disease PLoS One 8 2013 e67160
56. Y Hao, J Zhou, M Zhou et al. Serum levels of fibroblast growth factor 19 are inversely associated with coronary artery disease in chinese individuals PLoS One 8 2013 e72345
57. M Reiche, A Bachmann, U Lössner et al. Fibroblast Growth Factor 19 Serum Levels: Relation to Renal Function and Metabolic Parameters Horm Metab Res 42 2010 178 181
58. S Feng, O Dakhova, CJ Creighton et al. Endocrine fibroblast growth factor FGF19 promotes prostate cancer progression Cancer Res 73 2013 2551 2562
59. ET Sawey, M Chanrion, C Cai et al. Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by Oncogenomic screening Cancer Cell 19 2011 347 358
60. S Miura, N Mitsuhashi, H Shimizu et al. Fibroblast growth factor 19 expression correlates with tumor progression and poorer prognosis of hepatocellular carcinoma BMC Cancer 12 2012 56
61. J Hyeon, S Ahn, JJ Lee et al. Expression of fibroblast growth factor 19 is associated with recurrence and poor prognosis of hepatocellular carcinoma Dig Dis Sci 58 2013 1916 1922
62. X Wu, H Ge, B Lemon et al. Separating mitogenic and metabolic activities of fibroblast growth factor 19 (FGF19) Proc Natl Acad Sci USA 107 2010 14158 14163